Latest / Stock Movers / Boeing Jumps, Janux Therapeutics Plunges, Signet Slides
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, Podcasts, radio News.
- 0:08Speaker 2: The Stock Movers Report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 3: I'm Jim Stenebek along with Carrol Master. You are, let's
- 0:19Speaker 3: take a look at some stocks on the move today.
- 0:21Speaker 3: We're joined by Bloomberg Television Markets correspondent Nora Melinda Nour.
- 0:27Speaker 3: What do you have for us?
- 0:28Speaker 4: Boeing Well, yeah, say not knowing you love Boeing.
- 0:31Speaker 3: Well, I was going to let her do the review.
- 0:33Speaker 5: I was going to do a cute little intro, you know,
- 0:34Speaker 5: stock flying High.
- 0:35Speaker 4: I was sorry, I had a whole thing. Okay, nice
- 0:38Speaker 4: Carol three two one.
- 0:40Speaker 5: Yes shares a Boeing flying High. You're looking at ticker BA.
- 0:44Speaker 5: This is the best performing stock in the S and
- 0:46Speaker 5: P five hundred. And of course, this is after investors
- 0:48Speaker 5: are feeling really reassured after the CFO said that they
- 0:51Speaker 5: should expect billions of dollars in cash flow next year.
- 0:55Speaker 5: And of course, if you really kind of look at
- 0:56Speaker 5: what we've been seeing this year, we've been seeing the
- 0:58Speaker 5: company burning through two billion dollars in cash. So this
- 1:02Speaker 5: is a welcome reassurance that we're hearing from the company here.
- 1:05Speaker 5: So you are seeing shares of Boeing up as much
- 1:08Speaker 5: as what more than ten percent, rising for their best
- 1:11Speaker 5: days since April. So you really are seeing some strong
- 1:13Speaker 5: performance here. The street's clearly liking it.
- 1:15Speaker 1: Yeah, I mean number one gator. As you said, quite
- 1:18Speaker 1: a bump to the upside. Quite a bump sometimes in
- 1:21Speaker 1: a Boeing plane.
- 1:24Speaker 4: There's a lot of turbulence. We noticed that right, like
- 1:27Speaker 4: in some of our.
- 1:27Speaker 3: Are you talking about real turbulence, yeah, not equity market turbulence.
- 1:31Speaker 4: No, I'm not. Okay, well not at this moment.
- 1:33Speaker 5: So we're centered. Yeah, we're aligned. Now, Okay, where we
- 1:36Speaker 5: go next, Well, let's move over into healthcare. I've got
- 1:39Speaker 5: my eyes on Jane's Therapeutics. Now, this is the company
- 1:41Speaker 5: I had to dig a bit into. Was just a
- 1:43Speaker 5: little bit less than one billion dollar in market cap,
- 1:46Speaker 5: but it's a drug developer and it's seeing its worst
- 1:48Speaker 5: day ever. It's really really seeing a strong pullback today,
- 1:53Speaker 5: down as much as fifty one percent. It essentially did
- 1:56Speaker 5: have some interim data from its early stage trial in
- 1:59Speaker 5: terms of its prostate cancer therapy. The disappointed investors, so
- 2:04Speaker 5: really taking a beating today. I mean the stock on
- 2:06Speaker 5: a year today basis though, down sixty nine percent, So
- 2:09Speaker 5: it's been a pretty brutal year for this company.
- 2:11Speaker 1: It's so hard for some of these biotechs, right, who
- 2:14Speaker 1: are often centered sometimes around one individual drug. This may
- 2:18Speaker 1: not be the case for this one, but yeah, when
- 2:20Speaker 1: there's some disappointment. It's true for the major pharmaceuticals too,
- 2:23Speaker 1: if they're banking on something right. All right, that's doc
- 2:25Speaker 1: as you said, down today, down seventy percent year to date,
- 2:29Speaker 1: with eighteen percent of the float.
- 2:30Speaker 4: Short, Where would you like to go?
- 2:32Speaker 3: Signet Jewelers is where I want to go, although maybe
- 2:35Speaker 3: not enough people are going there.
- 2:36Speaker 5: Yeah, I mean, let's talk about the consumer. We've been
- 2:38Speaker 5: hearing about Black Friday data. There's so much what retail
- 2:41Speaker 5: earnings you've been getting as well. But in looking at Signet,
- 2:43Speaker 5: this is take our sig. We're seeing shares that are falling. Really,
- 2:47Speaker 5: of course, we are seeing this as the worst day
- 2:49Speaker 5: since April. This is after the company is essentially expressing
- 2:53Speaker 5: some caution as we look ahead into the holiday season,
- 2:56Speaker 5: which is a really key season for the company. If
- 2:58Speaker 5: you think about the fact that people are purchasing engagement
- 3:00Speaker 5: rings during that time period. As we head toward the
- 3:02Speaker 5: end of the year ahead of Valentine's Day next year,
- 3:06Speaker 5: they're saying that they expect to see some sort of
- 3:08Speaker 5: caution here when we think about the US consumer, despite
- 3:10Speaker 5: the fact that they did get earnings that were better
- 3:13Speaker 5: than expected. This is really what's dragging on the stock today.
- 3:16Speaker 3: This is the parent company of K Jewelers and Zail.
- 3:19Speaker 3: So you know, if you're in the market for that
- 3:22Speaker 3: type of jewelry, this company has a good view.
- 3:24Speaker 4: Do you mean that type of jewelry diamonds type of jewelry.
- 3:30Speaker 3: You know what I still wonder about the what's the
- 3:33Speaker 3: right way to talk about these.
- 3:36Speaker 5: Lab grown diamonds.
- 3:37Speaker 4: I think they're a great idea.
- 3:39Speaker 3: So the effect that that's having, but I don't know
- 3:42Speaker 3: that was before my time, like I was, you know,
- 3:46Speaker 3: unfortunately was stuck with a non lab grown diamond in
- 3:50Speaker 3: the whole engagement process. I know, I know, you know,
- 3:52Speaker 3: you talk to people who are a generation younger than
- 3:55Speaker 3: I am, and it's all about the lab grown Yeah, right.
- 3:58Speaker 5: Absolutely, apparently you can't even tell the difference.
- 4:00Speaker 4: We'll be right, they're the same thing, right, I don't know,
- 4:03Speaker 4: can they go as big?
- 4:04Speaker 5: That's a good question.
- 4:05Speaker 3: They go big and they are way less expensive.
- 4:07Speaker 4: You're way less expensive. There you go, which makes me
- 4:10Speaker 4: think about, you know, what really is the value of
- 4:12Speaker 4: these things?
- 4:13Speaker 3: Right?
- 4:13Speaker 2: I like that?
- 4:14Speaker 1: Like what I don't know what does it cost to
- 4:16Speaker 1: make a lab diamond? I guess you should assume that it's.
- 4:20Speaker 3: It's a very good question for this is a very
- 4:21Speaker 3: good question and discussion for de beers, and it's a
- 4:25Speaker 3: reason Whywana are having so much trouble, right ye, exactly.
- 4:31Speaker 2: The Stock Movers Report from Bloomberg Radio. Check back with
- 4:35Speaker 2: us throughout the day for the latest roundup of companies
- 4:38Speaker 2: making news on Wall Street and for the latest market
- 4:41Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 4:45Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 4:49Speaker 2: the Bloomberg Business app.